MEF2D Protein (Myc-DYKDDDDK Tag)
-
- Antigène Voir toutes MEF2D Protéines
- MEF2D (Myocyte Enhancer Factor 2D (MEF2D))
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette MEF2D protéine est marqué à la Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human MEF2D protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product MEF2D Protéine
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- MEF2D (Myocyte Enhancer Factor 2D (MEF2D))
- Autre désignation
- Mef2d (MEF2D Produits)
- Synonymes
- sl1 Protein, sl-1 Protein, XMEF2D Protein, MGC145245 Protein, C80750 Protein, myocyte enhancer factor 2D Protein, MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D) Protein, mef2d Protein, MEF2D Protein, Mef2d Protein
- Sujet
- This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants.
- Poids moléculaire
- 55.8 kDa
- NCBI Accession
- NP_005911
-